No news or media at this time
A $354M financing into a CNS program isn’t just a headline—it’s a signal. After years of hesitation, serious capital is re-engaging in neurology with a sharper lens on mechanism, patient selection, and clinical path.
A $354M financing into a CNS program isn’t just a headline—it’s a signal. After years of hesitation, serious capital is re-engaging in neurology with a sharper lens on mechanism, patient selection, and clinical path.